Literature DB >> 4141280

Phase I study of twice weekly 5-azacytidine (NSC-102816).

W R Vogler, S Arkun, E Velez-Garcia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4141280

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Azapyrimidine analogues: inhibition of viral DNA synthesis and protein synthesis in SV40 infected BSC-1 cells.

Authors:  M Johnson-Thompson; D Albury
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

3.  Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.

Authors:  Rosalyn A Juergens; John Wrangle; Frank P Vendetti; Sara C Murphy; Ming Zhao; Barbara Coleman; Rosa Sebree; Kristen Rodgers; Craig M Hooker; Noreli Franco; Beverly Lee; Salina Tsai; Igor Espinoza Delgado; Michelle A Rudek; Steven A Belinsky; James G Herman; Stephen B Baylin; Malcolm V Brock; Charles M Rudin
Journal:  Cancer Discov       Date:  2011-11-09       Impact factor: 39.397
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.